Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Burton, Jeremy P ^a,b   Wescombe, Philip A ^d   Macklaim, Jean M ^c   Chai, Melissa H C ^d   MacDonald, Kyle ^b   Hale, John D F ^d   Tagg, John ^d   Reid, Gregor ^a,b   Gloor, Gregory B ^c   Cadieux, Peter A ^b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; FIBRONECTIN; PROBIOTIC AGENT; RNA 16S;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL REPRODUCTION; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CELL ADHESION; CONTROLLED STUDY; DOSE RESPONSE; HEP 2 CELL; HOST CELL; HUMAN; HUMAN CELL; LOZENGE; MEGAPLASMID; MOUTH FLORA; PLASMID; RANDOMIZED CONTROLLED TRIAL; RNA GENE; SALIVA ANALYSIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SALIVARIUS M18;

BACTERIAL ADHESION; BACTERIAL PROTEINS; BACTERIOCINS; CELL LINE; CONJUGATION, GENETIC; HUMANS; MICROBIOTA; MOUTH; PLASMIDS; PROBIOTICS; RNA, RIBOSOMAL, 16S; SALIVA; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS;

EID: 84878967687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065991     Document Type: Article

References (55)

1. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, et al. (2000) Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66: 2578-2588.
2. Caglar E, Topcuoglu N, Cildir SK, Sandalli N, Kulekci G, (2009) Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics. Int J Paediatr Dent 19: 377-381.
3. Burton JP, Cadieux PA, Reid G, (2003) Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 69: 97-101.
4. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR, (2006) Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72: 3050-3053.
5. van Bokhorst-van de Veen H, Lee IC, Marco ML, Wels M, Bron PA, et al. (2012) Modulation of Lactobacillus plantarum Gastrointestinal Robustness by Fermentation Conditions Enables Identification of Bacterial Robustness Markers. PLoS One 7: e39053.
6. Bron PA, Wels M, Bongers RS, van Bokhorst-van de Veen H, Wiersma A, et al. (2012) Transcriptomes Reveal Genetic Signatures Underlying Physiological Variations Imposed by Different Fermentation Conditions in Lactobacillus plantarum. PLoS One 7: e38720.
7. Grzeskowiak L, Isolauri E, Salminen S, Gueimonde M, (2011) Manufacturing process influences properties of probiotic bacteria. Br J Nutr 105: 887-894.
8. Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, et al. (2006) Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek 90: 269-280.
9. Sybesma W, Molenaar D, van Ijcken W, Venema K, Kort R (2013) Genome instability in Lactobacillus rhamnosus GG. Appl Environ Microbiol.
10. Andersson DI, Hughes D, (1996) Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A 93: 906-907.
11. Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, et al. (2009) Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 80: 190-201.
12. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE, (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721-5732.
13. Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR, (2009) Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol 4: 819-835.
14. O'Shea EF, Cotter PD, Ross RP, Hill C (2013) Strategies to improve the bacteriocin protection provided by lactic acid bacteria. Curr Opin Biotechnol.
15. Dobson A, Crispie F, Rea MC, O'Sullivan O, Casey PG, et al. (2011) Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol Ecol 76: 602-614.
16. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, et al. (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104: 7617-7621.
17. Dierksen KP, Moore CJ, Inglis M, Wescombe PA, Tagg JR, (2007) The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue. FEMS Microbiol Ecol 59: 584-591.
18. Tagg JR, Dajani AS, Wannamaker LW, (1976) Bacteriocins of gram-positive bacteria. Bacteriol Rev 40: 722-756.
19. Heng NC, Haji-Ishak NS, Kalyan A, Wong AY, Lovric M, et al. (2011) Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18. J Bacteriol 193: 6402-6403.
20. Tagg JR, Bannister LV, (1979) "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol 12: 397-411.
21. Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, et al. (2007) Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol 73: 1107-1113.
22. Guedon E, Delorme C, Pons N, Cruaud C, Loux V, et al. (2011) Complete genome sequence of the commensal Streptococcus salivarius strain JIM8777. J Bacteriol 193: 5024-5025.
23. Kelstrup J, (1981) Extracellular polysaccharides of smooth and rough variants of Streptococcus salivarius. Scand J Dent Res 89: 374-383.
24. Tanzer JM, Kurasz AB, Clive J, (1985) Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R. Infect Immun 48: 44-50.
25. Burton J, Chilcott C, Moore C, Speiser G, Tagg J, (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. Journal of applied microbiology 100: 754-764.
26. Upton M, Tagg JR, Wescombe P, Jenkinson HF, (2001) Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol 183: 3931-3938.
27. Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, et al. (2011) Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One 6: e26602.
28. Gloor GB, Hummelen R, Macklaim JM, Dickson RJ, Fernandes AD, et al. (2010) Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One 5: e15406.
29. Dierksen KP, Ragland NL, Tagg JR, (2000) A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius. J Clin Microbiol 38: 643-650.
30. Miles AA, Misra SS, Irwin JO, (1938) The estimation of the bactericidal power of the blood. J Hyg (Lond) 38: 732-749.
31. Handley PS, Harty DW, Wyatt JE, Brown CR, Doran JP, et al. (1987) A comparison of the adhesion, coaggregation and cell-surface hydrophobicity properties of fibrillar and fimbriate strains of Streptococcus salivarius. J Gen Microbiol 133: 3207-3217.
32. Levesque C, Vadeboncoeur C, Frenette M, (2004) The csp operon of Streptococcus salivarius encodes two predicted cell-surface proteins, one of which, CspB, is associated with the fimbriae. Microbiology 150: 189-198.
33. Roos K, Grahn E, Holm SE, Johansson H, Lind L, (1993) Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol 25: 141-148.
34. Roos K, Hakansson EG, Holm S, (2001) Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 322: 210-212.
35. Roos K, Holm SE, Grahn E, Lind L, (1993) Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis 25: 31-35.
36. Sanders CC, Nelson GE, Sanders WE, (1977) Bacterial Interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A Streptococci. Infect Immun 16: 599-603.
37. Bochkov IA, Semina NA (1981) [Role of Streptococcus salivarius in maintaining the ecologic balance of the human nasopharynx]. Zh Mikrobiol Epidemiol Immunobiol: 38-41.
38. Dierksen KP, Tagg J (2000) The influence of indigenous bacteriocin-producing Streptococcus salivarius on the acquisition of Streptococcus pyogenes by primary school children in Dunedin, New Zealand. In: Martin DR, J T, editors. Streptococci and streptococcal diseases entering the new millenium. Auckland: Securacopy. 81-85.
39. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, et al. (2012) The Prevalence Of Streptococci And Increased Polymicrobial Diversity Associated With Cystic Fibrosis Patient Stability. J Bacteriol.
40. Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C (2013) Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther.
41. Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, et al. (2012) Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol 57: 1041-1047.
42. Ishijima SA, Hayama K, Burton JP, Reid G, Okada M, et al. (2012) Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78: 2190-2199.
43. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, et al. (2011) The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra106.
44. Jenkinson HF, Demuth DR, (1997) Structure, function and immunogenicity of streptococcal antigen I/II polypeptides. Mol Microbiol 23: 183-190.
45. Whittaker CJ, Klier CM, Kolenbrander PE, (1996) Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 50: 513-552.
46. Navarre WW, Schneewind O, (1999) Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63: 174-229.
47. Hamada S, Amano A, Kimura S, Nakagawa I, Kawabata S, et al. (1998) The importance of fimbriae in the virulence and ecology of some oral bacteria. Oral Microbiol Immunol 13: 129-138.
48. Handley PS, Carter PL, Fielding J, (1984) Streptococcus salivarius strains carry either fibrils or fimbriae on the cell surface. J Bacteriol 157: 64-72.
49. Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, et al. (2010) Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol 192: 1131-1142.
50. Foster JS, Kolenbrander PE, (2004) Development of a multispecies oral bacterial community in a saliva-conditioned flow cell. Appl Environ Microbiol 70: 4340-4348.
51. Postollec F, Norde W, de Vries J, Busscher HJ, van der Mei HC, (2006) Interactive forces between co-aggregating and non-co-aggregating oral bacterial pairs. J Dent Res 85: 231-234.
52. Levesque C, Lamothe J, Frenette M, (2003) Coaggregation of Streptococcus salivarius with periodontopathogens: evidence for involvement of fimbriae in the interaction with Prevotella intermedia. Oral Microbiol Immunol 18: 333-337.
53. Leblebicioglu B, Kulekci G, Ciftci S, Keskin F, Badur S, (2009) Salivary detection of periodontopathic bacteria and periodontal health status in dental students. Anaerobe 15: 82-86.
54. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, et al. (2008) The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 76: 4163-4175.
55. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, et al. (2010) Oral bacteria as potential probiotic for the pharyngeal mucosa. Appl Environ Microbiol.